Авторы

  • Raximboyeva G., Akramova D.
  • Mukhammedaminov B.

Ключевые слова:

Parkinson kasalligi, parkinsonizm plyus (P ), neyrodinamika, motor buzilishlar, kognitiv еtishmovchilik, emotsional o‘zgarishlar, klinik baholash, neyrodegeneratsiya.

Библиографические ссылки

Armstrong, M. J., & Litvan, I. (2019). Progressive supranuclear palsy and corticobasal degeneration: Advances in diagnosis and management. Lancet Neurology, 18(8), 760–772.

Bensimon, G., Ludolph, A., Agid, Y., Vidailhet, M., & Payan, C. (2020). Natural history of progressive supranuclear palsy: A prospective multicenter clinical study. Brain, 143(8), 2435–2447.

Boeve, B. F., & Litvan, I. (2017). Corticobasal degeneration. Seminars in Neurology, 37(5), 470–481.

Boxer, A. L., & Yu, J. T. (2021). Corticobasal syndrome: Clinical features and management. Journal of Neurology, 268(12), 44 80–4492.

Burn, D. J. (2019). Nonmotor symptoms in Parkinsonʼs disease and parkinsonism. Movement Disorders, 34(9), 1223–1231.

Colosimo, C., & Albanese, A. (2018). Differential diagnosis of parkinsonism: A clinicopathologic approach. Neurology, 90(3), 125–133

Coyle-Gilchrist, I. T., Dick, K. M., Patterson, K., & Rowe, J. B. (2016). Prevalence, characteristics, and survival of frontotemporal lobar degeneration syndromes. JAMA Neurology, 73(6), 720–728.

Dickson, D. W. (2018). Neuropathology of Parkinsonʼs disease and parkinsonism. Acta Neuropathologica, 135(3), 379–398.

Fanciulli, A., & Wenning, G. K. (2015). Multiple system atrophy. New England Journal of Medicine, 372(3), 249–263.

Fedorova, N. V., & Bhatia, K. P. (2020). Differential diagnosis of Parkinsonʼs disease. Practical Neurology, 20(6), 405–414.

Gelb, D. J., Oliver, E., & Gilman, S. (1999). Diagnostic criteria for Parkinson disease. Archives of Neurology, 56(1), 33–39.

Gibb, W. R. G., & Lees, A. J. (1988). The relevance of the Lewy body to the pathogenesis of idiopathic Parkinsonʼs disease. Journal of Neurology, Neurosurgery, and Psychiatry, 51(6), 745–752.

Gilman, S., Wenning, G. K., Low, P. A., & Brooks, D. J. (2008). Second consensus statement on the diagnosis of multiple system atrophy. Neurology, 71(9), 670–676.

Höglinger, G. U., Respondek, G., & Stamelou, M. (2017). Clinical diagnosis of progressive supranuclear palsy: The movement disorder society criteria. Movement Disorders, 32(6), 853–864.

Jankovic, J. (2019). Parkinsonʼs disease: Clinical features and diagnosis. Journal of Neurology, Neurosurgery & Psychiatry, 90 (1), 4–14.

Kaasinen, V., & Koller, W. C. (2019). Clinical presentation of atypical parkinsonism. Neurologic Clinics, 37(1), 79–90.

Litvan, I., & Agid, Y. (2016). Clinical research criteria for the diagnosis of progressive supranuclear palsy. Neurology, 47(1), 1–9.

Mahajan, A., & Johnson, D. K. (2020). Cognitive impairment in atypical parkinsonian syndromes. Frontiers in Neurology, 11, 567–575.

McFarland, N. R., & Hess, C. W. (2019). Atypical parkinsonism: Update and clinical approach. Practical Neurology, 19(2), 95–104.

Meissner, W. G., & Rascol, O. (2018). Movement disorders beyond Parkinsonʼs disease. Lancet Neurology, 17(10), 830–844.

Owen, A. M., & Robbins, T. W. (2017). Neuropsychological assessment in movement disorders. Brain, 140(10), 2526–2540.

Respondek, G., Kurz, C., & Brumberg, J. (2019). Which ante mortem clinical features predict progressive supranuclear palsy pathology? Movement Disorders, 34(9), 1283–1292.

Schrag, A., Ben-Shlomo, Y., & Quinn, N. P. (1999). Prevalence of progressive supranuclear palsy and multiple system atrophy: A population-based study. Lancet, 354(9192), 1771–1775.

Steele, J. C., Richardson, J. C., & Olszewski, J. (1964). Progressive supranuclear palsy: A heterogeneous degeneration involving the brain stem, basal ganglia, and cerebellum. Archives of Neurology, 10(4), 333–359.